BrightSpring Health Services Hits New 52-Week High of $64.70

BrightSpring Health Services, Inc. has reached a significant milestone by hitting a new 52-week high of USD 64.70 on June 16, 2026. This achievement underscores the company's remarkable performance in the Pharmaceuticals & Biotechnology sector, where it has demonstrated a staggering 472.17% increase over the past year, significantly outpacing the S&P 500's 24.5% growth during the same period. With a market capitalization of USD 8,193 million, BrightSpring is classified as a small-cap company. The stock's price-to-earnings (P/E) ratio stands at 41.00, reflecting its growth potential. The company has also reported a robust net profit growth of 50.96% in its latest quarterly results, contributing to its strong financial standing. BrightSpring's operational efficiency is highlighted by its highest operating cash flow of USD 511.52 million and a return on capital employed (ROCE) of 9.33%. Additionally, the company maintains a high debtor turnover ratio of 11.98 times, indicating effective management of receivables. With 100% institutional holdings, BrightSpring Health Services continues to solidify its position in the market as a reliable performer.